Washington Trust CO Bristol Myers Squibb CO Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Washington Trust CO holds 14,454 shares of BMY stock, worth $850,906. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,454

Previous 15,484 6.65%

Holding current value

$850,906

Previous $643,000 16.17%

% of portfolio

0.03%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$39.66 - $51.75 $40,849 - $53,302	-1,030 Reduced 6.65%	14,454 $747,000
Q2 2024 Jul 15, 2024	BUY	$40.25 - $52.99 $12,236 - $16,108	304 Added 2.0%	15,484 $643,000
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $13,434 - $15,232	-280 Reduced 1.81%	15,180 $823,000
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $43,341 - $51,717	894 Added 6.14%	15,460 $793,000
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $4,689 - $5,243	81 Added 0.56%	14,566 $845,000
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $21,024 - $23,344	-330 Reduced 2.23%	14,485 $926,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $965,477 - $1.1 Million	14,693 Added 104950.0%	14,707 $1.02 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $972,573 - $1.1 Million	-14,801 Reduced 99.91%	14 $1.02 Million
Q4 2022 Jul 27, 2023	BUY	$68.48 - $81.09 $7,395 - $8,757	108 Added 0.73%	14,815 $1.07 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $7,464 - $8,838	-109 Reduced 0.73%	14,815 $1.07 Million
Q3 2022 Oct 14, 2022	BUY	$0.13 - $76.84 $4 - $2,382	31 Added 0.21%	14,924 $1.06 Million
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $74,217 - $81,739	-1,022 Reduced 6.42%	14,893 $1.15 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $30,740 - $36,860	-500 Reduced 3.05%	15,915 $1.16 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $449,794 - $524,355	-8,387 Reduced 33.82%	16,415 $1.02 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $114,553 - $134,184	-1,936 Reduced 7.24%	24,802 $1.47 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $493,484 - $537,404	-7,971 Reduced 22.97%	26,738 $1.79 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $170,899 - $192,211	-2,880 Reduced 7.66%	34,709 $2.19 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $15,820 - $17,927	274 Added 0.73%	37,589 $2.33 Million
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $77,071 - $85,404	-1,342 Reduced 3.47%	37,315 $2.25 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $107,940 - $126,193	-1,969 Reduced 4.85%	38,657 $2.26 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $1.03 Million - $1.49 Million	-22,152 Reduced 35.29%	40,626 $2.27 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $2.54 Million - $3.31 Million	51,604 Added 461.82%	62,778 $4.03 Million
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $142,552 - $169,016	-3,333 Reduced 22.98%	11,174 $641,000
Q2 2019 Aug 07, 2019	BUY	$44.62 - $49.34 $124,043 - $137,165	2,780 Added 23.71%	14,507 $657,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $17,596 - $20,982	-390 Reduced 3.22%	11,727 $556,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $269,057 - $348,903	-5,518 Reduced 31.29%	12,117 $630,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $18,212 - $20,542	-330 Reduced 1.84%	17,635 $1.1 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $6,316 - $7,872	-125 Reduced 0.69%	17,965 $994,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $13,482 - $15,520	-225 Reduced 1.23%	18,090 $1.14 Million
Q4 2017 Feb 05, 2018	BUY	$59.94 - $65.35 $3,596 - $3,920	60 Added 0.33%	18,315 $1.12 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $1.01 Million - $1.16 Million	18,255	18,255 $1.16 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Bristol Myers Squibb CO Transaction History